Tian Jihua, Zeng Xing, Wan Jie, Gan Jiahua, Ke Chunjin, Guan Wei, Hu Zhiquan, Yang Chunguang
Department of Urology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China.
Department of Pathology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Oncol. 2022 Jan 26;11:819098. doi: 10.3389/fonc.2021.819098. eCollection 2021.
To compare the cause-specific survival (CSS) and overall survival (OS) of patients with localized T3a renal cell carcinoma (RCC) after partial nephrectomy (PN) or radical nephrectomy (RN).
We obtained the demographic and clinicopathological data of 7,127 patients with localized T3a RCC and who underwent PN or RN from the Surveillance, Epidemiology, and End Results (SEER) database. These patients were divided into fat invasion cohort and venous invasion cohort for subsequent analysis. Kaplan-Meier analysis (KMA) and univariate and multivariate Cox proportional hazards regression analyses were used to evaluate the effects of PN or RN on OS and CSS. Meanwhile, 65 cases with clinical T1 (cT1) RCC upstaged to pathological T3a (pT3a) who were treated in Tongji Hospital (TJH) from 2011 to 2020 and underwent PN or RN were identified.
In the study cohort, 2,085 (29.3%) patients died during the 1-172 months' follow-up, of whom 1,155 (16.2%) died of RCC. In the two cohorts of fat invasion and venous invasion, KMA indicated that the PN group had favorable survival ( < 0.001). However, after propensity score matching (PSM), univariate and multivariate Cox regression analyses showed that the PN and RN groups had comparable CSS in the fat invasion cohort ( = 0.075) and the venous invasion cohort ( = 0.190). During 1-104 months of follow-up, 9 cases in the Tongji cohort had disease recurrence. There was no significant difference in recurrence-free survival between the RN group and the PN group ( = 0.170).
Our analysis showed that after balancing these factors, patients with localized pT3a RCC receiving PN or RN can achieve comparable oncologic outcomes. PN is safe for selected T3a patients.
比较局限性T3a期肾细胞癌(RCC)患者行部分肾切除术(PN)或根治性肾切除术(RN)后的病因特异性生存率(CSS)和总生存率(OS)。
我们从监测、流行病学和最终结果(SEER)数据库中获取了7127例局限性T3a期RCC且接受了PN或RN的患者的人口统计学和临床病理数据。这些患者被分为脂肪浸润队列和静脉浸润队列以进行后续分析。采用Kaplan-Meier分析(KMA)以及单因素和多因素Cox比例风险回归分析来评估PN或RN对OS和CSS的影响。同时,确定了2011年至2020年在同济医院(TJH)接受治疗并接受了PN或RN的65例临床T1(cT1)期RCC升级为病理T3a(pT3a)的病例。
在研究队列中,2085例(29.3%)患者在1至172个月的随访期间死亡,其中1155例(16.2%)死于RCC。在脂肪浸润和静脉浸润这两个队列中,KMA表明PN组具有更好的生存率(<0.001)。然而,在倾向得分匹配(PSM)后,单因素和多因素Cox回归分析显示,在脂肪浸润队列(=0.075)和静脉浸润队列(=0.190)中,PN组和RN组的CSS相当。在1至104个月的随访期间,同济队列中有9例疾病复发。RN组和PN组之间的无复发生存率无显著差异(=0.170)。
我们的分析表明,在平衡这些因素后,局限性pT3a期RCC患者接受PN或RN可获得相当的肿瘤学结局。PN对选定的T3a期患者是安全的。